HSD

(redirected from Hypoactive sexual desire)
Also found in: Medical.
AcronymDefinition
HSDHuman Services Directory (various locations)
HSDHydraulic System Design (engineering)
HSDHonest Significant Difference (statistical test)
HSDHybrid Synergy Drive (Toyota/Lexus)
HSDHealth Service Delivery (various locations)
HSDHuman Services Department
HSDHealth and Social Development (various organizations)
HSDHigh Single Digit (finance)
HSDHarrisburg School District (Harrisburg, PA)
HSDHigh Speed Diesel
HSDHigh Speed Data
HSDHigh School Diploma
HSDHigh Safety Drive
HSDHigh Speed Draft
HSDHigh Speed Dubbing
HSDHost Storage Domain
HSDHybrid Synergy Drive
HSDHigh Speed Drive
HSDHigh School Dropout
HSDHillsboro School District (Hillsboro, OR)
HSDHighline School District (Washington)
HSDHuman Systems Dynamics (psychology)
HSDHawaii Skin Diver
HSDHealth Service District (Australia)
HSDHardware Software Development
HSDHistorical Society of Delaware
HSDHazelwood School District
HSDHousing Services Division (various locations)
HSDTukey's Honestly Significant Difference (aka the Tukey A Procedure; statistics; analysis)
HSDHigh School Drama
HSDHistory's Strongest Disciple (manga; Kenichi: The Mightiest Disciple)
HSDHigh Speed Digital
HSDHealth Services Department
HSDHypoactive Sexual Desire
HSDHorizontal Situation Display
HSDHealthcare Solutions Division (various locations)
HSDHardanger Sunnhordlandske Dampskipsselskap (Norway)
HSDHypertonic Saline Dextran
HSDHip Stability Drill (US Army)
HSDHigh Side Driver (electrical engineering)
HSDHighway Safety Division (US and Canada)
HSDHome Satellite Dish
HSDHigh Sexual Drive
HSDHartford Securities Distribution Company, Inc.
HSDHydrographic Surveys Division (NOAA)
HSDHealth and Safety Division
HSDHigh School of Dundee (Scotland)
HSDHuman Systems Division
HSDHome Delivery Service
HSDHicks Special Draught (beer)
HSDHigh School Diplomats (student program)
HSDHeat Sensing Device
HSDHigh Strength Deformed (steel)
HSDHigh Speed Deflectograph
HSDHardstyle Dance
HSD17-@beta Hydroxysteroid Dehydrogenase III Deficiency
HSDHamilton Standard Division
HSDHigh Sulphur Diesel
HSDHot-Swap Drive
HSDHigh Speed Drill
HSDHard Sphere Decoding
HSDHead Supported Device(s)
HSDHigh School Dublin
HSDHot Spot Detector
HSDHealth and Safety Document
HSDHonestly Significant Difference technique (ITU-T)
HSDHot-Swappable Dimensions
HSDHave Sweet Dreams (internet slang)
HSDHome School Debate
HSDHyde School of Dance (UK)
HSDHigh Sierra Drifters (Road Flat, CA)
HSDHot Surfer Dude
References in periodicals archive ?
Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study.
At a joint meeting of two FDA advisory panels in June, members of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted 18-6 that the overall benefit-risk profile of flibanserin supported approval for treating hypoactive sexual desire disorder (HSDD) in premenopausal women, provided that some risk management conditions were met.
At a joint meeting of two FDA advisory panels, members of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted 18 to 6 that the overall benefit-risk profile of flibanserin supported approval for treating hypoactive sexual desire disorder (HSDD) in premenopausal women, provided that certain risk management options beyond labeling were implemented.
Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder.
The company has completed the reconnect studies consisting of two pivotal Phase 3 clinical trials of bremelanotide for the treatment of female hypoactive sexual desire disorder (HSDD), a medical condition marked by low desire for sexual activity and a lack of sexual thoughts or fantasies, which causes a woman personal distress.
She reported on a phase lib randomized, double-blind, multicenter trial of 327 women who met diagnostic criteria for hypoactive sexual desire disorder or combined hypoactive sexual desire disorder/female sexual arousal disorder.
A snapshot of the global therapeutic scenario for Female Hypoactive Sexual Desire Disorder.
The Rose study: placebo-controlled randomized withdrawal trial of flibanserin for hypoactive sexual desire disorder in premenopausal women.
In a subgroup analysis, women with concomitant hypoactive sexual desire disorder reported less improvement with sildenafil than those without the disorder.
United States-based Sprout Pharmaceuticals' ADDYI is recommended by the US FDA's advisory committee for women who are facing hypoactive sexual desire disorder during the premenopausal period, it was reported on Friday.
A Food and Drug Administration advisory panel has unanimously agreed that concerns about the risks of flibanserin outweighed any evidence that the drug was effective as a treatment for premenopausal women with hypoactive sexual desire disorder.